Expression of ErbB receptors during pancreatic islet development and regrowth

in Journal of Endocrinology
Authors:
MR Kritzik
Search for other papers by MR Kritzik in
Current site
Google Scholar
PubMed
Close
,
T Krahl
Search for other papers by T Krahl in
Current site
Google Scholar
PubMed
Close
,
A Good
Search for other papers by A Good in
Current site
Google Scholar
PubMed
Close
,
D Gu
Search for other papers by D Gu in
Current site
Google Scholar
PubMed
Close
,
C Lai
Search for other papers by C Lai in
Current site
Google Scholar
PubMed
Close
,
H Fox
Search for other papers by H Fox in
Current site
Google Scholar
PubMed
Close
, and
N Sarvetnick
Search for other papers by N Sarvetnick in
Current site
Google Scholar
PubMed
Close
Free access

Sign up for journal news

We have characterized expression of the ErbB receptor family and one of its ligands, heregulin, in an effort to identify molecules associated with pancreatic development and regeneration. In addition to studying expression during fetal pancreatic development, we have also studied expression during pancreatic regeneration in the interferon-gamma (IFNgamma)-transgenic mouse, which exhibits significant duct cell proliferation and new islet formation. These studies demonstrate significant expression of the ErbB2, ErbB3, and ErbB4 receptors, in addition to heregulin isoforms, in the developing murine fetal pancreas. We also report significant ductal expression of these proteins during IFNgamma-mediated pancreatic regeneration. This striking expression was absent in 1-week-old neonates, but was clearly visible in pups by 5 weeks of age. These data therefore indicate that ErbB receptor and ligand expression decline by birth in both the IFNbeta-transgenic and non-transgenic mice, and that expression resumes early in postnatal life in the IFNbeta-transgenic mice. The expression of ErbB receptor family members at sites of islet development and regrowth suggests that these molecules might be relevant to these processes.

 

  • Collapse
  • Expand